Total Payments
$876.26
2023 Payments
$258.30
Companies
20
Transactions
55
Medicare Patients
1,263
Medicare Billing
$114,868
Payment Breakdown by Category
Food & Beverage$796.86 (90.9%)
Gifts$59.40 (6.8%)
Education$20.00 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $796.86 | 53 | 90.9% |
| Gift | $59.40 | 1 | 6.8% |
| Education | $20.00 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insulet Corporation | $281.06 | 19 | $0 (2022) |
| MannKind Corporation | $106.50 | 4 | $0 (2023) |
| Novo Nordisk Inc | $79.99 | 6 | $0 (2022) |
| Medtronic, Inc. | $75.36 | 4 | $0 (2023) |
| Dexcom, Inc. | $41.51 | 3 | $0 (2023) |
| IBSA Pharma Inc. | $36.76 | 2 | $0 (2021) |
| Amgen Inc. | $36.01 | 2 | $0 (2023) |
| Xeris Pharmaceuticals, Inc. | $29.68 | 2 | $0 (2023) |
| Medtronic MiniMed, Inc. | $27.62 | 2 | $0 (2017) |
| Ascendis Pharma Inc | $19.71 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $258.30 | 13 | MannKind Corporation ($106.50) |
| 2022 | $107.10 | 7 | Insulet Corporation ($48.70) |
| 2021 | $157.93 | 11 | Insulet Corporation ($115.96) |
| 2020 | $75.42 | 5 | Novo Nordisk Inc ($26.59) |
| 2019 | $121.10 | 8 | Insulet Corporation ($39.42) |
| 2018 | $97.32 | 7 | Insulet Corporation ($45.51) |
| 2017 | $59.09 | 4 | Insulet Corporation ($31.47) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Endocrinology | ||||||
| 11/21/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Diabetes | ||||||
| 09/22/2023 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: Automated insulin delivery system | ||||||
| 09/05/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/30/2023 | MannKind Corporation | AFREZZA (Drug) | Education | In-kind items and services | $20.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/03/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: DIABETES MEDICINE | ||||||
| 07/25/2023 | MannKind Corporation | AFREZZA (Drug) | Gift | In-kind items and services | $59.40 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/11/2023 | Medtronic, Inc. | MINIMED 770G (Device) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Durable Pump | ||||||
| 04/27/2023 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 04/19/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Cardiology | ||||||
| 04/14/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Endocrinology | ||||||
| 02/17/2023 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $19.71 | General |
| 09/28/2022 | Medtronic, Inc. | MINIMED 770G (Device) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Durable Pump | ||||||
| 08/11/2022 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $14.90 | General |
| Category: Insulin Pump | ||||||
| 08/11/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Diabetes | ||||||
| 06/29/2022 | Medtronic, Inc. | MINIMED 770G (Device) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Durable Pump | ||||||
| 06/09/2022 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.35 | General |
| Category: Insulin Pump | ||||||
| 03/25/2022 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $15.45 | General |
| Category: Insulin Pump | ||||||
| 02/16/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Endocrinology | ||||||
| 12/10/2021 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $10.95 | General |
| Category: Insulin Pump | ||||||
| 11/11/2021 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $11.32 | General |
| Category: Insulin Pump | ||||||
| 11/05/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/31/2021 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $14.94 | General |
| Category: Insulin Pump | ||||||
| 07/23/2021 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.02 | General |
| Category: Insulin Pump | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 199 | 323 | $39,958 | $18,888 |
| 2022 | 5 | 253 | 413 | $48,086 | $24,019 |
| 2021 | 5 | 336 | 571 | $56,552 | $33,112 |
| 2020 | 5 | 475 | 683 | $77,292 | $38,849 |
Total Patients
1,263
Total Services
1,990
Medicare Billing
$114,868
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 152 | $27,980 | $13,680 | 48.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $7,750 | $3,658 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 18 | $2,520 | $1,161 | 46.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 61 | 122 | $1,708 | $388.79 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 201 | $32,090 | $17,418 | 54.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $6,566 | $2,709 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 33 | $3,470 | $2,120 | 61.1% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 16 | 16 | $4,000 | $1,321 | 33.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 65 | 140 | $1,960 | $451.18 | 23.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 145 | 253 | $35,420 | $23,389 | 66.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $9,000 | $4,097 | 45.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 58 | $5,220 | $3,524 | 67.5% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 16 | 16 | $4,000 | $1,420 | 35.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 94 | 208 | $2,912 | $682.24 | 23.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 182 | 279 | $39,060 | $21,277 | 54.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 100 | 100 | $25,000 | $11,968 | 47.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 56 | $5,040 | $3,170 | 62.9% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 20 | 20 | $5,000 | $1,700 | 34.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 123 | 228 | $3,192 | $733.82 | 23.0% |
About Agha Khan
Agha Khan is a Endocrinology, Diabetes & Metabolism healthcare provider based in Pueblo, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649336546.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Agha Khan has received a total of $876.26 in payments from pharmaceutical and medical device companies, with $258.30 received in 2023. These payments were reported across 55 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($796.86).
As a Medicare-enrolled provider, Khan has provided services to 1,263 Medicare beneficiaries, totaling 1,990 services with total Medicare billing of $114,868. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Pueblo, CO
- Active Since 12/28/2006
- Last Updated 10/07/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649336546
Products in Payments
- Omnipod (Device) $281.06
- AFREZZA (Drug) $106.50
- MINIMED 770G (Device) $53.61
- Ozempic (Drug) $51.90
- Tirosint (Drug) $36.76
- Repatha (Biological) $36.01
- GVOKE HYPOPEN (Drug) $29.68
- Dexcom G6 Transmitter (Medical Supply) $28.44
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $21.75
- Tymlos (Drug) $18.56
- Eversense (Device) $17.00
- FARXIGA (Drug) $16.17
- BAQSIMI (Drug) $14.93
- PRALUENT (Biological) $14.78
- Victoza (Drug) $14.76
- Minimed 670G System (Device) $13.95
- Minimed 630G (Device) $13.67
- Cryvista (Drug) $13.51
- Tresiba (Drug) $13.33
- DEXCOM G6 TRANSMITTER (Device) $13.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Pueblo
Ana Ramirez Berlioz, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $3,483
Endocrinology, Diabetes & Metabolism $3,483
Kenneth Dernovsek, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,994
Endocrinology, Diabetes & Metabolism $1,994
Dr. William Gonzales, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $32.88
Endocrinology, Diabetes & Metabolism $32.88
Robert Alsever, M.d, M.D
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism